Page 48 - IJB-6-4
P. 48

Design and AM of a medical face shield
















































           Figure 5. Finite element analysis verification virtual prototype.

           production  time  per  unit).  Details  related  to  the   The survey results were interpreted as having a
           AM procedures  and  prototypes  produced  are       high satisfaction level since the answers given to
           given in Figure 6.                                  question no. 9 related to satisfaction of using this
                                                               product  were  very  positive  overall,  in  addition
           2.9 Physical prototype trials
                                                               to  the  positive  responses  to  the  other  questions
           The  model  of  Candidate  5  was  highlighted      (40% of those completing the survey found the
           through the TFA and the prototyping stage was       product to be “excellent,” 40% found the product
           successfully  realized.  In  addition,  to  obtain   to be “good,” 17% found the product “average,”
           first-hand  user  opinions  about  the  prototype   7% found the product to be “poor,” and no-one
           of  Candidate  5,  a  survey  was  conducted.       found  the  product  “insufficient”).  Thus,  for  the
           The  survey  was  completed  by  health  service    final evaluation, it was decided that Candidate 5
           workers (medical doctors, nurses, and the other     as  the  final  product  design  should  be  approved
           health service workers) at Antalya Training and     and the design evaluation undertaken in this
           Research Hospital, Antalya, Turkey in April 2020.   research was finalized. The participation details,
           Ten questions related to the face shield product    survey questions, variation of the answers given
           evaluation were answered by 15 HWs who used         to these questions, and the pictures obtained from
           the  product  in  routine  daily  hospital  activities.   the trials are provided in Figure 7.


           44                          International Journal of Bioprinting (2020)–Volume 6, Issue 4
   43   44   45   46   47   48   49   50   51   52   53